Pharma Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Boston Scientific Corp.
Boston Scientific launches new balloon catheters
July 4th, 2006
Boston Scientific Corp. (BSX) announced that it has received FDA clearance to launch its Sterling Monorail and Over-the-Wire Balloon Dilatation Catheter in the United States. The balloon catheters are available in a broad range of sizes, offering interventionalists superb clinical versatility. Both balloon catheter platforms are engineered for use in the renal and lower extremity arteries, as well as in dialysis fistula. In addition, the Sterling Monorail Catheter received a specific indication for use in the carotid arteries as both a pre- and post-dilatation balloon. The Sterling Balloon Dilatation Catheter sets a new standard in peripheral...
Source: Pharma Law Weekly (2006-07-04)
|
